Highest-materiality recent filing
Westlake Chemical Partners appoints Tommy Darby as VP & CAO; Holy moves to IR
Tommy E. Darby, 45, named VP & Chief Accounting Officer of WLKP's GP and Westlake Corp., effective Aug 31, 2026.
Westlake Chemical Partners Q2 net income $14.2M ($0.40/unit); distribution $0.4714/unit
Net income attributable to Partnership $14.2M, slightly below $14.6M in Q2 2025.
Westlake Chemical Partners Q1 net income $14.2M, up from $4.9M; distribution $0.4714/unit
Net income attributable to Partnership of $14.2M ($0.40/unit) vs $4.9M in Q1 2025.
Westlake Chemical Partners appoints Jonathan Baksht as CFO effective June 15, 2026
Jonathan H. Baksht appointed Senior Vice President and CFO of general partner, effective June 15, 2026.
Westlake Chemical Partners Q4 net income $14.5M, coverage ratio 1.13x, distribution $0.4714
Q4 net income $14.5M ($0.41/unit) vs $15.0M in Q4 2024; full year net income $48.7M ($1.38/unit), down from $62.4M.
Westlake Chemical Partners CFO M. Steven Bender to retire upon successor appointment
M. Steven Bender notified retirement as EVP and CFO of General Partner, effective when successor appointed.
WLKP Q3 net income $14.7M ($0.42/unit); renews ethylene deal through 2027 at same terms
Q3 net income $14.7M ($0.42/unit), down from $18.1M YoY; operating cash flow $105.2M, down $20.9M YoY.
Westlake Chemical Partners Q2 net income $14.6M; distribution $0.4714/unit declared
Net income $14.6M ($0.41/unit) vs $14.4M in Q2 2024; flat YoY.
Net income attributable to partnership of $4.9M ($0.14/unit) vs Q1 2024 net income of $14.8M.
Westlake Chemical Partners Q4 net income $15M flat YoY; full-year net income up 15% to $62.4M
Q4 2024 net income $15.0M ($0.43/unit) vs $14.3M Q4 2023; full-year $62.4M ($1.77/unit) vs $54.3M.
Westlake Chemical Partners Q3 2024 net income $18.1M, up 37% YoY; distribution $0.4714/unit
Net income attributable to Partnership $18.1M ($0.51/unit), up from $13.2M in Q3 2023.
Westlake Chemical Partners Q2 net income $14.4M ($0.41/unit); distribution declared
Net income $14.4M ($0.41/unit) up from $11.9M YoY; operating cash flow $121.9M, +$23.4M.
Westlake Chemical Partners appoints Jean-Marc Gilson CEO; Chao family transitions to chairman roles
James Chao becomes Senior Chairman; Albert Chao becomes Executive Chairman of the General Partner.
Jeff Holy becomes VP & CAO from VP/Treasurer; Johnathan Zoeller becomes VP/Treasurer from VP/CAO, effective immediately.
Westlake Chemical Partners Q1 net income flat at $14.8M; declares $0.4714/unit distribution
Net income attributable to Partnership $14.8M ($0.42/unit), essentially flat vs Q1 2023 $14.9M.
Westlake Chemical Partners Q4 net income down 15% YoY; coverage ratio falls to 0.94x
Q4 2023 net income $14.3M ($0.41/unit) vs $16.8M in Q4 2022; full year $54.3M vs $64.2M.
Net income attributable to Partnership was $13.2M ($0.37/unit) in Q3 2023, down from $14.8M in Q3 2022 due to higher interest expense.
Westlake Chemical Partners Q2 net income $11.9M ($0.34/unit) down 27% YoY; distribution unchanged
Net income $11.9M ($0.34/unit), down 27% YoY from $16.4M; driven by Calvert City turnaround and higher interest expense.
Westlake Chemical Partners Q1 net income $14.9M ($0.42/unit); distribution of $0.4714 declared
Net income attributable to Partnership $14.9M ($0.42/unit), down from $16.2M YoY due to higher interest expense.
Westlake Chemical Partners appoints Lisa Friel to board, replacing Angela Minas
Lisa Friel appointed as independent director of Westlake Chemical Partners GP LLC, effective April 27, 2023.
Director Angela A. Minas resigns from Westlake Chemical Partners GP Board
Angela A. Minas resigned from the Board of Directors of the General Partner, effective upon appointment of her successor.
Westlake Chemical Partners Q4 net income $16.8M, down 43% YoY; distribution held at $0.4714/unit
Q4 2022 net income attributable to Partnership $16.8M ($0.48/unit) vs $29.5M in Q4 2021, down on lower buyer deficiency fee and higher interest expense.
Westlake Chemical Partners Q3 net income up 16% to $14.8M; declares $0.4714 distribution
Net income attributable to Partnership $14.8M ($0.42/unit) vs $12.8M in Q3 2021, up 16%.
Westlake Chemical Partners Q2 net income $16.4M, down 35% YoY; distribution steady at $0.4714
Net income attributable to Partnership $16.4M ($0.47/unit) vs $25.1M in Q2 2021, primarily due to prior-year buyer deficiency fee.
Westlake Chemical Partners extends revolver maturities to July 2027, switches to SOFR
OpCo Revolver maturity extended to July 12, 2027; interest now SOFR + 1.75% margin + 0.10% spread.
Westlake Chemical Partners Q1 net income $16.2M; declares $0.4714 distribution
Net income attributable to Partnership $16.2M ($0.46/unit), up from $15.1M in Q1 2021.
Westlake Chemical Partners reports record FY2021 net income $82.5M; Q4 distribution $0.4714/unit
Q4 2021 net income attributable to Partnership $29.5M ($0.84/unit), up from $15.0M in Q4 2020.
Westlake Chemical Partners Q3 net income down 31% to $12.8M; distribution steady at $0.4714/unit
Net income attributable to Partnership was $12.8M ($0.36/unit), down from $18.5M in Q3 2020.
Westlake Chemical Partners Q2 net income record $25.1M, up 68% YoY; distribution $0.4714/unit
Net income $25.1M ($0.71/unit) vs $14.9M Q2 2020; record quarterly net income.
On August 31, 2026, Westlake Chemical Partners LP (the “Partnership”) announced that Tommy E. Darby, age 45, was appointed to the position of Vice President, Chief Accounting Officer of Westlake Chemical Partners GP LLC, the general partner of the Partnership (the “General Partner”), effective immediately.
Mr. Darby will succeed Jeffrey A. Holy, who will transition from his current position of Vice President, Chief Accounting Officer of the General Partner to the position of Vice President, Finance and Investor Relations of the General Partner, effective concurrent with the appointment of Mr. Darby.
Albert Chao, formerly the President, Chief Executive Officer and Director of the General Partner, transitioned to the position of Executive Chairman of the Board of the General Partner;
Jean-Marc Gilson was appointed as the President, Chief Executive Officer and Director of the General Partner.
Mr. Holy transitioned to the position of Vice President, Chief Accounting Officer from his prior role as Vice President and Treasurer.
Mr. Zoeller transitioned to the position of Vice President and Treasurer from his prior role as Vice President, Chief Accounting Officer.
Ms. Minas’ retirement from the Board was not the result of any disagreement with the General Partner or the Partnership and was effective on April 27, 2023.
On April 27, 2023, Westlake International Services Corporation, as sole member of Westlake Chemical Partners GP LLC (the “General Partner”), the general partner of Westlake Chemical Partners LP (the “Partnership”), appointed Ms. Lisa A. Friel to serve as an independent member of the General Partner’s board of directors (the “Board”).
On March 3, 2023, Angela A. Minas informed Westlake Chemical Partners GP LLC (the “General Partner”), the general partner of Westlake Chemical Partners LP (the “Partnership”), of her decision to resign from the Board of Directors of the General Partner effective upon the appointment of her successor.
Max materiality 0.75 · Median 0.60 · Most common event earnings